Contract Pharma Magazine
June 2024
-
Breaking Barriers: Strategic Use of FSP Models to Expand Trials into Non-Footprint Countries
Leveraging functional service provider models to enhance global clinical trial reach and inclusion.06.19.24
-
Exploring Oligonucleotide Drugs: An Overview of Pharmacokinetic & Bioanalytical Strategies
Nucleic acid-based drugs represent one of the most promising fields in new drug development.06.19.24
-
Indian Pharmaceutical Industry at a Crossroads
India has an opportunity to strengthen its position in the global pharmaceutical market.06.19.24
-
Stability Testing: On Trend
Exploring considerations for commissioning stability storage and analysis projects.06.19.24
-
The Importance of Change Control within the Laboratory Setting
Exploring best practices for the employment of quality risk management within laboratory operations.06.19.24
-
Contract Labs Grow Versatile as Demands Go Diverse
Changing molecules and changing partner needs.06.19.24
-
CRO Industry Report
R&D trends, challenges in today’s market, and growth drivers and opportunities.06.19.24
-
Sponsored ContentPharma Matters Q&A: ElementElement’s Khanh Ngo Courtney talks about analytical considerations of biological therapeutic impurities.06.18.24
-
Sponsored ContentPharma Matters Q&A: Cardinal HealthJosh Marsh from Cardinal Health talks about the recent shifts in patient support services and the evolution of a digital hub.06.12.24
-
ColumnsQuality Management Systems: The Future of Quality OversightThe overarching goal is to have future-looking systems be designed in such a way that make it harder to do the wrong thing, and ultimately enhance drug quality.06.19.24
-
ColumnsPreparing for the Un-Preparable InterviewBehavioral questions drive today’s process.06.19.24
